HITOSHI TERUI

Dr. HITOSHI TERUI

orcid
Tohoku Univ. Dermatology

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2022 in Science Immunology
Verified
Journal Article
Closed access
HITOSHI TERUIHITOSHI TERUI
HITOSHI TERUI
KYKenshi Yamasaki
Kenshi Yamasaki
MWMoyuka Wada-Irimada
Moyuka Wada-Irimada
MOMayuko Onodera-Amagai
Mayuko Onodera-Amagai
NHNaokazu Hatchome
Naokazu Hatchome
SASetsuya Aiba
Setsuya Aiba
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by inflammation of various organs such as skin, kidneys, bones, and brain and the presence of autoantibodies. Although the cause of SLE is not completely understood, environmental factors, genetic susceptibility, hormone factors, and environmental factors are thought to play essential roles in the pathogenesis of SLE. Among environmental factors, the microbiota are linked to the development of different autoimmune diseases. The microbiota in the nasal cavity and gut are involved in SLE development, but the influence of skin microbiota is still unclear. Here, we demonstrated that epithelial cell–specific IκBζ-deficient ( Nfkbiz ΔK5 ) mice showed spontaneous skin inflammation with increased abundance of Staphylococcus aureus on the skin. When S. aureus was epicutaneously applied on Nfkbiz ΔK5 mice, Nfkbiz ΔK5 mice developed SLE-associated autoantibodies, anti-dsDNA antibodies, anti-Sm antibodies, and glomerulonephritis with IgG deposition. Epicutaneous S. aureus application significantly increased staphylococcal colonization on the skin of Nfkbiz ΔK5 mice with reduced expression of several antimicrobial peptides in the skin. This staphylococcal skin colonization promoted caspase-mediated keratinocyte apoptosis and neutrophil activation, inducing the interleukin-23 (IL-23)/IL-17 immune response by activating dendritic cells and T cells. Furthermore, the subcutaneous administration of anti–IL-23p19 and anti–IL-17A antibodies alleviated the systemic autoimmune response. Together, these findings underscore epithelial-immune cross-talk disturbances caused by skin dysbiosis as an essential mediator inducing autoimmune diseases.

1 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HITOSHI TERUIHITOSHI TERUI
HITOSHI TERUI
YAYoshihide Asano
Yoshihide Asano
Psoriasis is a chronic inflammatory skin disease with a high prevalence of cardiovascular disease (CVD), obesity, dyslipidemia, hypertension, diabetes mellitus, and metabolic syndrome. Among them, CVD is the most common cause of morbidity and mortality in psoriasis patients. Since CVD is associated with considerable morbidity and mortality, primary care clinicians are increasingly committed to reducing the risk of CVD in patients with psoriasis. Biologics targeting TNF-α, IL-12/23, and IL-17 are systemic therapies that can dramatically improve the condition of psoriasis. Recent studies have reported that these inflammatory cytokine signals may promote atherosclerosis, suggesting that biologics might be effective for improving psoriasis as well as reducing the risk of CVD. Here, we reviewed cardiovascular risk in psoriasis patients, the association between psoriatic inflammation and atherosclerosis, and the efficacy of biologics for reducing the risk of cardiovascular diseases.

Verified
Journal Article
Open access
PDF file
RARyo Amagai
Ryo Amagai
Toshiya TakahashiToshiya Takahashi
Toshiya Takahashi
HITOSHI TERUIHITOSHI TERUI
HITOSHI TERUI
TFTaku Fujimura
Taku Fujimura
KYKenshi Yamasaki
Kenshi Yamasaki
YAYoshihide Asano
Yoshihide Asano
An active form of cathelicidin antimicrobial peptide, LL-37, has immunomodulatory and stimulatory effects, though the specific pathways are not clear. The purpose of this study was to identify the cellular pathways by which LL-37 amplifies the inflammation induced by damage-associated molecular patterns (DAMPs). We performed DNA microarray, reverse transcription polymerase chain reaction, immunoblotting, and proximity ligation assays using cultured keratinocytes treated with LL-37 and/or the DAMP poly(I:C), a synthetic double-stranded RNA. In contrast to the combination of LL-37 and poly(I:C), LL-37 alone induced genes related to biological metabolic processes such as VEGFA and PTGS2 (COX-2). Inhibition of FPR2, a known receptor for cathelicidin, partially suppressed the induction of VEGFA and PTGS2. Importantly, VEGFA and PTGS2 induced by LL-37 alone were diminished by the knockdown of scavenger receptors including SCARB1 (SR-B1), OLR1 (SR-E1), and AGER (SR-J1). Moreover, LL-37 alone, as well as the combination of LL-37 and poly(I:C), showed proximity to the scavenger receptors, indicating that LL-37 acts via scavenger receptors and intermediates between them and poly(I:C). These results showed that the broad function of cathelicidin is generally dependent on scavenger receptors. Therefore, inhibitors of scavenger receptors or non-functional mock cathelicidin peptides may serve as new anti-inflammatory and immunosuppressive agents.

4 July 2019 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
Toshiya TakahashiToshiya Takahashi
Toshiya Takahashi
KYKenshi Yamasaki
Kenshi Yamasaki
HITOSHI TERUIHITOSHI TERUI
HITOSHI TERUI
RORyoko Omori
Ryoko Omori
KTKenichiro Tsuchiyama
Kenichiro Tsuchiyama
SASetsuya Aiba
Setsuya Aiba

29 March 2018 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
YKYutaka Kimura
Yutaka Kimura
CFChizu Fujimura
Chizu Fujimura
YIYumiko Ito
Yumiko Ito
Toshiya TakahashiToshiya Takahashi
Toshiya Takahashi
HITOSHI TERUIHITOSHI TERUI
HITOSHI TERUI
SASetsuya Aiba
Setsuya Aiba

5 February 2018 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AWAkiko Watabe
Akiko Watabe
KYKenshi Yamasaki
Kenshi Yamasaki
MAMasayuki Asano
Masayuki Asano
YKYumi Kanbayashi
Yumi Kanbayashi
MNMei Nasu‐Tamabuchi
Mei Nasu‐Tamabuchi
SASetsuya Aiba
Setsuya Aiba